After Hours Summary: Quiet after hours session; JBLU -1.1% lower as court rules against Northeast Alliance deal with AAL; but SAVE +2.3% higher as JBLU plans to focus more on itAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: None
Companies trading higher in after hours in reaction to news: ASLN +3.9% (to discuss Phase 2b topline data from TREK-AD trial), VSTM +3.6% (announces design for confirmatory trial of Avutometinib and Defactinib), LUNR +2.5% (stock offering by selling shareholder), NKTX +2.4% (names new CFO), SAVE +2.3% (JBLU issues statement on Northeast Alliance with AAL; disagrees with court ruling, but does not plan to appeal; JBLU will now turn even more focus to proposed combination with SAVE), MRUS +1.8% (FDA grants second Breakthrough Therapy Designation for Zenocutuzumab), MGNI +1.7% (chosen by Foxtel Media to enable programmatic advertising on BINGE Basic), SVM +1.1% (reports high-grade silver-lead drill results), BAC +0.3% (increases dividend), SQM +0.2% (new long term supply agreement with LG Energy), RMD +0.1% (acquires Somnoware)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: None
Companies trading lower in after hours in reaction to news: XOM -1.2% (details items that will impact Q2 results), SLDP -1.2% (Ford extends the term of Joint Development Agreement with SLDP), JBLU -1.1% (JBLU issues statement on Northeast Alliance with AAL; disagrees with court ruling, but does not plan to appeal; JBLU will now turn even more focus to proposed combination with SAVE), NKLA -0.7% (awarded $41.9 mln grant by California to build refueling stations), AAL -0.4% (JBLU issues statement on Northeast Alliance with AAL; disagrees with court ruling, but does not plan to appeal; JBLU will now turn even more focus to proposed combination with SAVE), F -0.2% (Ford extends the term of Joint Development Agreement with SLDP)